80 related articles for article (PubMed ID: 12482131)
1. Microangiopathic hemolysis refractory to plasmapheresis responding to docetaxel and cisplatin: a case report.
Marcoullis G; Abebe L; Jain D; Talusan R; Bhagwati N; Wiernik PH
Med Oncol; 2002; 19(3):189-92. PubMed ID: 12482131
[TBL] [Abstract][Full Text] [Related]
2. Prompt resolution of acute disseminated intravascular coagulation with docetaxel and cisplatin in hormone refractory prostate cancer.
Avancès C; Jacot W; Sénesse P; Culine S
J Urol; 2002 Oct; 168(4 Pt 1):1496. PubMed ID: 12352431
[No Abstract] [Full Text] [Related]
3. Successful treatment of metastatic hormone-refractory prostate cancer with malignant pericardial tamponade using docetaxel.
Hayes-Lattin BM; Kovach PA; Henner WD; Beer TM
Urology; 2002 Jan; 59(1):137. PubMed ID: 11796304
[TBL] [Abstract][Full Text] [Related]
4. A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer.
Chen LT; Liu TW; Wu CW; Chung TR; Shiah HS; Jan CM; Liu JM; Whang-Peng J; Chang JY
Oncology; 2002; 63(3):239-47. PubMed ID: 12381903
[TBL] [Abstract][Full Text] [Related]
5. Recurrent gastric adenocarcinoma with unusual metastatic localization and excellent response to docetaxel and 5-FU continuous infusion.
Thuss-Patience PC; Kretzschmar A; Krenn V; Dörken B; Reichardt P
Onkologie; 2003 Feb; 26(1):63-5. PubMed ID: 12624520
[TBL] [Abstract][Full Text] [Related]
6. New paclitaxel-cisplatin based chemotherapy regimen for advanced stage, recurrent, or refractory neuroblastoma-preliminary report.
Surico G; Muggeo P; De Leonardis F; Rigillo N
Med Pediatr Oncol; 2003 Feb; 40(2):130-2. PubMed ID: 12461803
[No Abstract] [Full Text] [Related]
7. Study shows 2-year survival advantage for docetaxel.
Expert Rev Anticancer Ther; 2001 Oct; 1(3):323-4. PubMed ID: 12113094
[No Abstract] [Full Text] [Related]
8. A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer.
Cascinu S; Graziano F; Barni S; Labianca R; Comella G; Casaretti R; Frontini L; Catalano V; Baldelli AM; Catalano G
Br J Cancer; 2001 Feb; 84(4):470-4. PubMed ID: 11207039
[TBL] [Abstract][Full Text] [Related]
9. Docetaxel: today's results and tomorrow's promises.
Hortobagyi GN
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):11-4. PubMed ID: 9364535
[No Abstract] [Full Text] [Related]
10. Phase II study of docetaxel and cisplatin combination chemotherapy in metastatic or unresectable localized non-small-cell lung cancer.
Kim YH; Kim JS; Choi YH; In KH; Park HS; Hong DS; Jeong TJ; Lee YY; Nam E; Lee SN; Lee KS; Kim HK
Int J Clin Oncol; 2002 Apr; 7(2):114-9. PubMed ID: 12018108
[TBL] [Abstract][Full Text] [Related]
11. Gastric perforation induced by combination chemotherapy in a patient with long-term use of corticosteroids.
Yamazawa K; Matsui H; Sekiya S
Int J Gynaecol Obstet; 2002 Aug; 78(2):165-6. PubMed ID: 12175721
[No Abstract] [Full Text] [Related]
12. [New drugs for unresectable or recurrent gastric cancer--paclitaxel and docetaxel].
Yoshida M; Ohtsu A
Nihon Rinsho; 2001 Apr; 59 Suppl 4():404-8. PubMed ID: 11424415
[No Abstract] [Full Text] [Related]
13. [Extensive bone marrow necrosis and thrombotic microangiopathic anemia revealing disseminated adenocarcinoma].
Chevalet P; Moreau A; Muller F; Berthelot JM; Hamidou M; Prost A
Presse Med; 1998 Jul 4-11; 27(24):1213-5. PubMed ID: 9767775
[TBL] [Abstract][Full Text] [Related]
14. [Comparative pharmaco-economic analysis of docetaxel with cisplatin and cyclophosphamide with cisplatin in first-line chemotherapy of advanced ovarian cancer].
Gorbunova VA; Khokhlova SV; Komarova BP; Orel NF; Besova NS
Vopr Onkol; 2002; 48(6):695-9. PubMed ID: 12530266
[No Abstract] [Full Text] [Related]
15. Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group.
Fossella F; Pereira JR; von Pawel J; Pluzanska A; Gorbounova V; Kaukel E; Mattson KV; Ramlau R; Szczesna A; Fidias P; Millward M; Belani CP
J Clin Oncol; 2003 Aug; 21(16):3016-24. PubMed ID: 12837811
[TBL] [Abstract][Full Text] [Related]
16. Primarily unknown origin adenocarcinoma metastasis in bone marrow presenting with thrombotic thrombocytopenic purpura: a case report.
Koroglu M; Erkurt MA; Berber I; Kuku I; Kaya E; Ozkahraman A; Aydin NE
Transfus Apher Sci; 2013 Oct; 49(2):341-4. PubMed ID: 23830187
[TBL] [Abstract][Full Text] [Related]
17. Docetaxel and carboplatin combination chemotherapy for recurrent endometrial cancer.
Obata H; Aoki Y; Watanabe M; Matsushita H; Yahata T; Fujita K; Kurata H; Tanaka K
Int J Clin Oncol; 2003 Feb; 8(1):53-5. PubMed ID: 12601544
[TBL] [Abstract][Full Text] [Related]
18. [Microangiopathic hemolytic anemia in cancers. A case with remission after chemotherapy].
Mariette X; Oberlin F; Brigant S; Koeger AC; Camus JP
Rev Med Interne; 1988; 9(3):297-9. PubMed ID: 3406589
[No Abstract] [Full Text] [Related]
19. Taxane-based chemotherapy for patients with carcinoma of unknown primary site.
Greco FA; Gray J; Burris HA; Erland JB; Morrissey LH; Hainsworth JD
Cancer J; 2001; 7(3):203-12. PubMed ID: 11419028
[TBL] [Abstract][Full Text] [Related]
20. Docetaxel/platinum combination provides quality-of-life advantage over vinorelbine/cisplatin in advanced lung cancer.
Oncology (Williston Park); 2002 Aug; 16(8):1052. PubMed ID: 12201644
[No Abstract] [Full Text] [Related]
[Next] [New Search]
